4295 San Felipe St #310, Houston, TX 77027 • 713 621-0483
4295 San Felipe St, Houston, TX 77027
3964 Inverness Dr, Houston, TX 77019
1800 Saint James Pl, Houston, TX 77056
1800 Saint James Pl #308, Houston, TX 77056
3350 Mccue Rd, Houston, TX 77056
Katy, TX
West Palm Beach, FL
2902 Chaucer Dr, Montgomery, TX 77356
499 Lasher Rd, Tivoli, NY 12583
Palm Beach, FL
Work
Company:
Picoscript
2000 to 2008
Position:
General partner
Education
Degree:
Bachelors, Bachelor of Arts
School / High School:
Vanderbilt University
1964 to 1968
Specialities:
Business Administration, Management, Architecture, Business, Business Administration and Management
Skills
Business Strategy • Portfolio Management • Start Ups • Leadership Development • Leadership • Public Speaking • Public Relations • Valuation • Real Estate • Entrepreneurship • Strategic Planning • Selling • Management Consulting • Business Planning • Business Development • Strategy • Mergers and Acquisitions • Negotiation • New Business Development
Picoscript 2000 - 2008
General Partner
The Lasher Company 2000 - 2008
Owner, the Lasher Company, Inc
Education:
Vanderbilt University 1964 - 1968
Bachelors, Bachelor of Arts, Business Administration, Management, Architecture, Business, Business Administration and Management
Skills:
Business Strategy Portfolio Management Start Ups Leadership Development Leadership Public Speaking Public Relations Valuation Real Estate Entrepreneurship Strategic Planning Selling Management Consulting Business Planning Business Development Strategy Mergers and Acquisitions Negotiation New Business Development
Us Patents
Dna-Based Plasmid Formulations And Vaccines And Prophylactics Containing The Same
The invention is a general method for improving the performance of the DNA-based vaccines. The method utilizes a complex DNA-generated profile of antigens to extend the effects of DNA-based vaccines and to broaden the immune response. This broadened immune response in turn improves the protection of the recipient from divergent (but related) strains of a pathogen. In addition, it effectively improves the efficacy of DNA-based vaccines used for treatment of viral diseases, including acquired immunity disorder (AIDS). One embodiment, where the target viral pathogen is HIV (the causative agent for aids), the method identifies an orderly set of plasmids of related sequences that may be used to prime a broad and strong immune response to HLA-restricted viral antigens. This mixture of plasmids is thus capable of priming an appropriate immune response to reduce the viral burden in HIV infected patients or to protect uninfected patients from HIV infection.
James Frost - The Woodlands TX, US Alfred Lasher - Houston TX, US Steven Widen - Pearland TX, US
Assignee:
Picoscript Ltd., L.L.P. - Houston TX
International Classification:
C12Q 1/24 C12M 1/36
US Classification:
435030000, 435286300, 435286400
Abstract:
The present invention relates to a robotic apparatus and method for automating the spreading of a biologic sample on a plate, wherein the robot includes at least one effector arm to hold and shake the plate and a pipetting arm to deliver the sample to the plate. The present invention also includes the spreading of the biologic sample being assisted by at least one bead being rolled on the interior bottom surface of the plate and then removed from the plate.
Dna-Based Plasmid Formulations And Vaccines And Prophylactics Containing The Same
Alfred W. Lasher - Houston TX, US Steven G. Widen - Galveston TX, US
International Classification:
A61K 48/00 A61K 39/21 A61K 39/12 A61K 39/00
Abstract:
The invention is a general method for improving the performance of the DNA-based vaccines. The method utilizes a complex DNA-generated profile of antigens to extend the effects of DNA-based vaccines and to broaden the immune response. This broadened immune response in turn improves the protection of the recipient from divergent (but related) strains of a pathogen. In addition, it effectively improves the efficacy of DNA-based vaccines used for treatment of viral diseases, including acquired immunity disorder (AIDS). One embodiment, where the target viral pathogen is HIV (the causative agent for aids), the method identifies an orderly set of plasmids of related sequences that may be used to prime a broad and strong immune response to HLA-restricted viral antigens. This mixture of plasmids is thus capable of priming an appropriate immune response to reduce the viral burden in HIV infected patients or to protect uninfected patients from HIV infection.
Youtube
GOODBYE TO AL LASHER'S ELECTRONICS
Al Lasher's Electronics was a "Mom & Pop" type retail outlet that was ...
Duration:
10m 39s
Al Lasher Electronics (Charlie Hunter) Cover
Al Lasher Electronics Charlie Hunter George Sluppick Michael Blake ...
Duration:
5m
Al Lasher Electronics (Live)
Provided to YouTube by The Orchard Enterprises Al Lasher Electronics (...
Duration:
6m 5s
gmp lasher demo 3.mpg
C2 Aerial Cable Lasher.
Duration:
40s
Episode #49: The Law with Ben Lasher
Ben Lasher is a Conservation Officer with the Michigan Department of N...
Duration:
2h 27m 13s
Kyle Lasher Overcomes Deafness to Become High...
Kyle Lasher does not let any obstacle stand in the way of his love of ...
Alfred Lasher's Public Profile on Plaxo. Plaxo helps members like Alfred Lasher keep in touch with the people who really matter, helping them to connect, ...